EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.634
https://www.valueinhealthjournal.com/article/S1098-3015(22)02838-8/fulltext
Title :
EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02838-8&doi=10.1016/j.jval.2022.09.634
First page :
Section Title :
Open access? :
No
Section Order :
10169